Carisma Therapeutics Inc. Comprehensive Income
Carisma Therapeutics Inc. reported Comprehensive Income of -$60.48 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-03-31
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$17.64M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$12.70M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$11.16M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$18.98M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$60.48M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$86.84M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$61.27M.
- Carisma Therapeutics Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$336.00K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$17.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$30.34M derived: sum of 2 quarters · filed 2025-03-31 | -$41.50M derived: sum of 3 quarters · filed 2025-03-31 | -$60.48M 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | -$12.70M 10-Q · filed 2024-11-07 | -$23.86M derived: sum of 2 quarters · filed 2024-11-07 | -$42.84M 10-Q · filed 2024-11-07 | -$64.17M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2024-06-30 | -$11.16M 10-Q · filed 2024-08-08 | -$30.14M 10-Q · filed 2024-08-08 | -$51.47M derived: sum of 3 quarters · filed 2025-03-31 | -$72.77M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2024-03-31 | -$18.98M 10-Q · filed 2024-05-09 | -$40.31M derived: sum of 2 quarters · filed 2025-03-31 | -$61.60M derived: sum of 3 quarters · filed 2025-03-31 | -$81.35M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-12-31 | -$21.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$42.63M derived: sum of 2 quarters · filed 2025-03-31 | -$62.37M derived: sum of 3 quarters · filed 2025-03-31 | -$86.84M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$21.30M 10-Q · filed 2024-11-07 | -$41.04M derived: sum of 2 quarters · filed 2024-11-07 | -$65.51M 10-Q · filed 2024-11-07 | -$82.13M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$19.75M 10-Q · filed 2024-08-08 | -$44.21M 10-Q · filed 2024-08-08 | -$60.83M derived: sum of 3 quarters · filed 2024-08-08 | -$79.12M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$24.46M 10-Q · filed 2024-05-09 | -$41.09M derived: sum of 2 quarters · filed 2024-05-09 | -$59.38M derived: sum of 3 quarters · filed 2024-05-09 | -$74.26M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$16.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$34.91M derived: sum of 2 quarters · filed 2024-04-01 | -$49.80M derived: sum of 3 quarters · filed 2024-04-01 | -$61.27M 10-K · filed 2024-04-01 | -$20.43M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$18.29M 10-Q · filed 2023-11-09 | $20.50M 10-Q · filed 2022-11-07 | -$33.18M derived: sum of 2 quarters · filed 2023-11-09 | -$44.65M 10-Q · filed 2023-11-09 | -$12.54M 10-Q · filed 2022-11-07 | -$25.04M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | -$14.89M 10-Q · filed 2023-08-10 | -$32.24M 10-Q · filed 2022-08-08 | -$26.36M 10-Q · filed 2023-08-10 | -$33.05M 10-Q · filed 2022-08-08 | -$6.75M derived: sum of 3 quarters · filed 2023-08-10 | $64.92M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$807.00K 10-Q · filed 2022-05-09 | $8.14M derived: sum of 2 quarters · filed 2023-02-28 | $79.81M derived: sum of 3 quarters · filed 2023-02-28 | $54.37M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $80.62M derived: sum of 2 quarters · filed 2023-02-28 | $55.18M derived: sum of 3 quarters · filed 2023-02-28 | -$336.00K 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $71.67M 10-Q · filed 2022-11-07 | $46.23M derived: sum of 2 quarters · filed 2022-11-07 | -$9.28M 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | -$25.44M 10-Q/A · filed 2022-08-25 | -$80.95M 10-Q/A · filed 2022-08-25 | ||||||
| 2021-03-31 | -$55.51M 10-Q · filed 2022-05-09 | |||||||
| 2020-12-31 | -$22.40M 10-K · filed 2023-02-28 | |||||||
| 2019-12-31 | -$107.50M 10-K · filed 2022-02-28 |